A2QVS9 AF NFT

mRNA cap guanine-N7 methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeih6lpgb5smjruykfz3hlgkhr3merjkre54nbdu53e7222rr7ymlxu/metadata.json
IPFS of structure file: 
bafybeifimvkkvpfblbdnckz2elabtvpzkqku7vbcky7tvvcuryizooil3m/AF-A2QVS9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x31853d823D7eABEB1119607e22Fd7fE552272B84
First NFT owner address (bech32): 
genesis1xxznmq3a0647kygevplz9ltlu4fzw2uyp90787
Current NFT ID #226193 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
226193
Accession (UniProt):
A2QVS9
Name::
mRNA cap guanine-N7 methyltransferase
Experimental Method:
Predicted structure
Sequence source:
ASPERGILLUS NIGER (STRAIN CBS 513.88 / FGSC A1513)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A2QVS9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A2QVS9|MCES_ASPNC mRNA cap guanine-N7 methyltransferase OS=Aspergillus niger (strain CBS 513.88 / FGSC A1513) OX=425011 GN=abd1 PE=3 SV=1 MASKEEERTGQRPSISMYDPARDRWEEQPVVPAEPASASASIEATPTQTSEAKPVHDSTVTSTSESLHLPQTTTIEPSQQPEQQQKQPPIPTPPSSQSRRKHKINKMGDYYRSGSADAYAEQSSPAADSHKRKLEDETSEQQPPADQANDRPISKRKRLEERHQKLRKRGQAPPSAYSRRDGDETAARAAPRPRSPSPPLPPRSPSPEVQARQRKRPGGGARRGLVDPQTLRRRQEERERALEEDAMRNSQSRGVTDIVRQHYNAVPQRGREWRKTESKIKGLRSFNNWVKSTLIQKFSPDEEFEKRLLVIDLGCGKGGDLGKWQLAPQPVDLYVGLDPAEVSIIQARERYAGMRSGRGPRGGRRGGPPLFHGEFRSKDCFGEWLGDVDIVQQVGIDPNVGPGGSMMASRWGGGGFDVVTSMFAIHYAFESEEKARQMLRNVAGCLKKGGRFIGVCPNSDIISARVEEEAKAEWGNSIYRVRFPGDTPEDGIFRPPFGWKYSYFMEEAVGEIPEYVVPWEAFRALTEEYNLELQYRKPFMEVWRDEKDDPELGPLSERMGVRDRTTGELTMTPEEQEAVSKYTPLGFTSAEGESANGTGFYHAFCFYKV